Avanos Medical, Inc. (AVNS) financial statements (2021 and earlier)

Company profile

Business Address 5405 WINDWARD PARKWAY
ALPHARETTA, GA 30004
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments112205385220114130149
Cash and cash equivalents112205385220114130149
Receivables168164151203190225234
Inventory, net of allowances, customer advances and progress billings16914612191273303283
Inventory16914612191273303283
Disposal group, including discontinued operation   633   
Deferred tax assets    2
Other undisclosed current assets19245714171917
Total current assets:4675397141,161594676685
Noncurrent Assets
Operating lease, right-of-use asset4864
Property, plant and equipment175185154110261280278
Intangible assets, net (including goodwill)9609859529141,1991,0281,534
Goodwill8038017847651,0299451,426
Intangible assets, net (excluding goodwill)15818416814917083108
Disposal group, including discontinued operation, noncurrent assets      3
Deferred income tax assets1016
Other noncurrent assets1211844228
Deferred tax assets, net   15 
Other undisclosed noncurrent assets  6815  
Total noncurrent assets:1,2061,2611,1201,0351,4781,3241,843
TOTAL ASSETS:1,6731,8001,8332,1962,0722,0002,528
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities151198264316324315422
Accounts payable6883170171173163169
Accrued liabilities8311594145151152183
Employee-related liabilities      46
Taxes payable      23
Debt 15 40  4
Disposal group, including discontinued operation   34   
Other undisclosed current liabilities16     (70)
Total current liabilities:166213264390324315356
Noncurrent Liabilities
Long-term debt and lease obligation53311248541579578632
Long-term debt, excluding current maturities 248248541579578632
Operating lease, liability5363
Liabilities, other than long-term debt, including:17112450662848
Accounts payable and accrued liabilities      2
Deferred tax liabilities, net   2428
Deferred income tax liabilities6 
Other liabilities11112032302848
Other undisclosed liabilities, other than long-term debt  41836(24)(30)
Other undisclosed noncurrent liabilities180    (554) 
Total noncurrent liabilities:25032227259164552680
Other undisclosed liabilities     578 
Total liabilities:4165345369819699451,036
Stockholders' equity
Stockholders' equity attributable to parent1,2571,2651,2971,2151,1031,0551,491
Common stock1111111
Treasury stock, value(10)(9)(5)(4)(2)(1) 
Additional paid in capital1,6091,5941,5781,5511,5331,5181,503
Accumulated other comprehensive loss(28)(32)(34)(31)(50)(43)(19)
Retained earnings (accumulated deficit)(316)(288)(242)(300)(379)(419)7
Total stockholders' equity:1,2571,2651,2971,2151,1031,0551,491
TOTAL LIABILITIES AND EQUITY:1,6731,8001,8332,1962,0722,0002,528

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues7156986526121,5921,5741,672
Revenue, net6121,5921,5741,672
Cost of revenue
(Cost of Goods and Services Sold)
(342)(295)(261)(275)(1,034)(1,043)(1,124)
Gross profit:373402391337558532549
Operating expenses(368)(437)(382)(360)(452)(905)(539)
Other operating income (expense), net(52)(21)(8)(20)(18)(5)4
Other undisclosed operating income      81
Operating income (loss):(46)(56)1(43)87(378)94
Nonoperating income
(Investment Income, Nonoperating)
1783103
Interest and debt expense(16)(15)(26)(32)(33)(33)(6)
Income (loss) from continuing operations before income taxes:(61)(64)(18)(72)55(411)91
Income tax expense (benefit)33181040(16)(16)(64)
Income (loss) from continuing operations:(27)(46)(9)(32)40(426)27
Income from discontinued operations  98    
Net income (loss):(27)(46)90(32)40(426)27
Other undisclosed net income (loss) attributable to parent  (32)111   
Net income (loss) available to common stockholders, diluted:(27)(46)587940(426)27

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(27)(46)90(32)40(426)27
Other comprehensive income (loss)42(2)19(7)(24) 
Comprehensive income (loss):(23)(44)88(13)33(450)27
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (32)111  (11)
Comprehensive income (loss), net of tax, attributable to parent:(23)(44)559833(450)16

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: